Screening and quantitative analysis of Q-Marker for anti-renal fibrosis of Shenqi shenshuai mixture based on untargeted metabolomics and bioinformatics
- VernacularTitle:基于非靶向代谢组学和生物信息学的参芪肾衰合剂抗肾纤维化质量标志物的筛选与定量分析
- Author:
Yuhang ZHOU
1
;
Yuqi LI
1
;
Zhuo GAO
1
;
Qingfeng RUAN
2
;
Xiaoxuan ZENG
2
;
Hui WANG
3
;
Chuanqi HUANG
1
;
Hongfeng XU
4
Author Information
1. School of Pharmacy，Hubei University of Chinese Medicine，Wuhan 430065，China;Dept. of Pharmacy，Wuhan No.1 Hospital，Wuhan 430022，China
2. Dept. of Pharmacy，Wuhan No.1 Hospital，Wuhan 430022，China
3. Hubei Center for Adverse Drug （Medical Device） Reaction Monitoring，Wuhan 430060，China
4. School of Pharmacy，Hubei University of Chinese Medicine，Wuhan 430065，China
- Publication Type:Journal Article
- Keywords:
Shenqi shenshuai mixture;
Q-Marker;
untargeted metabolomics;
network pharmacology;
content determination
- From:
China Pharmacy
2026;37(13):1716-1721
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To screen and quantitatively analyze the quality marker （Q-Marker） associated with anti-renal fibrosis in Shenqi shenshuai mixture （SQSS）， so as to provide references for the analysis of pharmacodynamic substances and new drug transformation of SQSS. METHODS The chemical components of SQSS were characterized by untargeted metabolomics. Combined with network pharmacology， gene expression omnibus （GEO） and connectivity map （CMAP） databases， the anti-renal fibrosis Q-Markers of SQSS were screened. HPLC-MS/MS was applied to determine the contents of Q-Markers in 10 batches of SQSS. RESULTS A total of 1 319 compounds were identified from SQSS via untargeted metabolomics，and 84 active ingredients with anti-renal fibrosis activity were further screened out， such as formononetin. Nine anti-renal fibrosis Q-Markers were obtained by network pharmacology and GEO database， including berberine， quercetin， honokiol， nicotinamide， daidzein， coumarin， kaempferol， formononetin and amygdalin. The quantitative results showed that the average contents of the above components （excluding amygdalin） in 10 batches of SQSS were 2.523， 1.942， 26.848， 1.415， 0.692， 0.171， 0.374， 7.401 μg/mL， respectively. CONCLUSIONS Nine anti-renal fibrosis Q-Markers of SQSS were screened in this study， and the contents of eight among them were determined. The results can provide a basis for elucidating the pharmacodynamic material basis and promoting the new drug transformation of SQSS.
